Sanctura XR, a new long-acting formulation of trospium for overactive bladder

You'll soon see Sanctura XR, a new long-acting formulation of trospium for overactive bladder.

It will compete with the other long-acting antimuscarinics...Ditropan XL and Oxytrol (oxybutynin)...Detrol LA (tolterodine)...Vesicare (solifenacin)...and Enablex (darifenacin).

These drugs seem to be similar in efficacy and cost. The big differences are the frequency of side effects and drug interactions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote